BioCentriq™ is a cell & gene therapy process development and clinical manufacturing center. We produce autologous and allogeneic cell therapies and gene therapies, and immunotherapies, including monoclonal antibodies and proteins, and vaccines.
Contact us to add description: email@example.com
BioCentriq is a cell and gene Therapy process development and clinical manufacturing center. Many more medical treatment strategies are capitalizing on cell and gene therapy approaches. BioCentriq is facilitating this process by improving the speed, cost and quality of developing and manufacturing clinical grade material. Although specializing in viral vector process development, BioCentriq has established quality systems in a variety of cell and vector types and supports the release of both autologous and allogeneic drug products. BioCentriq’s clients are small and medium-sized biotech companies who are in IND submission through to Phase 3 clinical trials.